Abstract: While a gene family by definition will have homologies in sequence, the "functional genomics" or characterization of the functionality of siblings can reveal significant differences. One gene family that shares an ATPbinding cassette (ABC) sequence motif is comprised of members named "ABC Transporters." Until 1989, the members of this family were primarily ATPases that pumped compounds out of cells and many were linked to multidrug resistance (MDR). Hence, at that time the function of the members of the ABC gene family appeared equally homologous to their structure. Since then the discovery of new members, like the cystic fibrosis transmembrane conductance regulator (CFTR) Cl -channel and the sulfonylurea receptor (SUR), increased diversity and the homologous structure seemed to no longer link to homologous function. In this mini-review we will introduce two parallel investigations, separated by 10 years, where researchers re-examined the functionality of the human ABC transporters, CFTR and MDR, under the hypothesis that the structurally similar ABC transporters must have similarities in function.
INTRODUCTION
"Structural genomics," the cloning and sequencing of genes, has revolutionized biology and generated a credible classification of gene families and subgroups. Although a gene family by definition will have sequence homologies, the "functional genomics," or characterization of functionality, of siblings can reveal significant differences and diverge from the common expectation that form and function are tightly linked.
One gene family that shares an ATP-binding cassette (ABC) sequence motif is so named "ABC Transporters." Mutations of genes in this family have been linked to various clinical maladies including: ALD gene-adrenoleukodystrophy, SUR gene-diabetes, CFTR gene-cystic fibrosis, MDR gene-multidrug resistance in cancer [1] . For many years the genetically related ABC transporters appeared uniformly to split ATP and use that energy to "pump" substrates upstream across cell membranes. After the discovery of a new ABC transporter gene in 1989, the cystic fibrosis transmembrane conductance regulator (CFTR), perspectives began to change. Since structure is aligned with function, the finding that CFTR was not a pump, but, in fact, a Cl -channel, led investigators to re-examine the activity of other ABC transporters.
In 1992, the function of the multidrug resistance protein (the MDR gene product is also called P-glycoprotein) was revised. New data indicated that it might be "bifunctional." The transporter, believed to split ATP and pump *Address correspondence to this author at the Cystic Fibrosis Research Laboratory, 2100 Biomedical and Physical Sciences Bldg., Michigan State University, East Lansing, MI 48824, USA; Tel: 517-355-6475, Ext. 1311; Fax: 517-355-5125; E-mail: luckie@msu.edu chemotherapy drugs out of cancer cells, was also found to be tightly linked to volume-activated Cl -channel activity. In fact, in an article by Valverde et al. (1992) [2] , investigators used the known homology between MDR and CFTR to propose that MDR was a Cl -channel, as well as a drug pump. As a result, the study of Cl -channel activity of MDR became an active subfield in ABC gene research. Similarly, although the CFTR gene was found to be a cAMP-activated Cl -channel, the possibility that it might be responsible for other processes has often been tested [3] . Recent studies suggest that CFTR may be bifunctional (both a Cl -channel and Cl -/HCO 3 -exchanger) and this has now become an important new subfield in CF research in 2002 [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] .
In the early 1990s, the authors began an NIH-funded investigation entitled "Bifunctionality of ABC Transporters" and became participants in these two parallel subfields where structural and functional genomics of human CFTR and MDR played a central role. In this mini-review we will first introduce some members of the ABC Transporter family and then focus on research into the potential "bifunctionality" of both CFTR and MDR. Lastly, we will suggest an evolutionary hypothesis which may explain how these genes evolved and examine what evolutionary theory can, and cannot tell us about the functional outcomes of the evolutionary process. This mini-review is by no means a comprehensive examination of the fields, multidrug resistance, cystic fibrosis, or evolutionary biology but instead attempts to highlight some events from the past that may inform the present/future.
What is an ABC Transporter?
The term, "ABC Transporter" was first applied to unite the relations of this gene family, by Christopher Higgins in a 1992 review [19] . Members of this superfamily have various genomic similarities but the one that has proven central is the presence of an "ATP-binding cassette" (ABC) motif. An ABC transporter typically contains two transmembrane domains (TMDs) and two nucleotide (ATP) binding domains (NBD's) (Fig. (1) ). Each NBD contains the ABC motif where two sequences common to all ATP-binding proteins, the Walker A and B domains, are combined with a third, C motif, specific to this family. One ABC gene often contains all four domains (two TMD and two NBD) on one long peptide, however, the four domains can also be expressed from separate genes that then assemble at the membrane to form the fully functioning unit (Fig. (1) ).
Early in 2001, Michael Dean and colleagues published two comprehensive reviews of the ABC transporter family tree [20, 21] . Dean et al. took advantage of the latest sequence information from the international and private genome projects and generated the most up to date family classification indicated in Table ( 1) [20, 21] . While this mini-review only deals with human ABC transporters, for further reference we direct readers to reviews on non-human ABC Transporters [22] , the evolution of the ABC family [23] and its walker domains [24] . For the purposes of this review we will focus on the human MDR and CFTR members of this family found in two separate groups, the "ABCB" and "ABCC" subfamilies of the ABC Transporters (Table (1)) .
ABCB Subfamily (MDR and Siblings)
The ABCB subfamily is composed of seven known transporters (Table (1)) and the multidrug resistance (MDR) or P-glycoprotein (PGY1) gene is identified as gene ABCB1. The terminology "P-glycoprotein" or "MDR" can sometimes be used interchangeably to describe the gene, RNA or the protein depending on the context, and the name ABCB1 adds a third identity. For simplicity, in this review we will refer to it as MDR (Fig. (1) ). The MDR (ABCB1) gene is normally only expressed in liver cells and those involved in the blood brain barrier and is thought to be involved in protecting cells from toxic agents [25, 26] . It was originally discovered as an over-expressed protein in some drug-resistant tumor cell lines. The ABCB transporters appear to be responsible for movement of molecules across these cellular membranes and in particular, MDR, appears to pump toxic chemotherapy drugs out (efflux) of cells [25, 26] , although the mechanism is uncertain [27] . Investigators found that when a tumor cell over-expressed MDR, it became resistant to a wide variety of chemotherapy drugs, hence the terminology "multidrug resistance". The expression of MDR can be significant from the a clinical perspective, since resistant cancers quickly become fatal.
Other members of this subfamily transport phosphatidylcholine (PC) and bile salts (ABCB4 and B11), aid immune cells by tranporting antigens into their ER (ABCB2 and B3 (TAP)), as well as, can manage iron flux in the lysosome (ABCB9) or the mitochondria (ABCB6, B7, B8, and B10) [20, 21] . Failures in these processes (impairing the immune system) are significant and the clinical relevance of this gene family continues with members in the ABCC subgroup which includes CFTR.
ABCC Subfamily (CFTR and Siblings)
The ABCC subfamily contains 12 transporters (Table (1)). Two of these members do not fit well under the definition that ABC transporters are "pumps." The CFTR (ABCC6) protein is unique among ABC proteins in that it is a cAMP-regulated chloride ion channel [28] . Cystic fibrosis is a disease caused by mutations in the gene for CFTR (Fig.  (1) ) [29] [30] [31] [32] . In cystic fibrosis (CF), the disease pathology in many organs is attributed primarily to impaired Cl -conductance in apical membranes of wet epithelia [33] . The ABCC8 gene (SUR1) is another ABC transporter that is not a pump. SUR1 is a high affinity receptor for the drug sulfonylurea [34] . Sulfonylureas are widely used to increase insulin secretion in patients with non-insulin-dependent diabetes. These drugs bind to the ABCC8 protein that closes a potassium channel (Kir) and triggers insulin secretion. If there is a mutation in the SUR1 gene the secretion of insulin is disturbed. In fact, the gene was identified as the locus for familial persistent hyperinsulinemic hypoglycemia of infancy, an autosomal recessive disorder characterized by unregulated insulin secretion [34] . The remaining ABCC family members are nine MRP-related genes associated with a different form of multidrug resistance and appear to pump glutathione conjugates across the cell membrane [35] .
ABC TRANSPORTERS 1992: "IS MDR BIFUNC-TIONAL?"
Animal cells lyse (explode) due to osmotic swelling if they are exposed to a hypotonic conditions for too long. Cells respond to the dangers of swelling by activating channels that allow the efflux of osmolytes and inorganic ions (especially Cl -) followed by water. This important process is known as regulatory volume decrease (RVD) and one ubiquitous and well-studied pathway for osmolyte release involves the "volume sensitive osmolyte and anion channel" (VSOAC) [36] . Identifying and cloning swelling channels has been a long-term effort in the field that is yet to yield a convincing result. Yet in 1992, a report in the journal Nature suggested that the molecular identity of VSOAC was finally found.
Is MDR Both a Drug Pump and a Swelling-activated Cl -

Channel?
In 1992, the multidrug-resistance MDR protein, thought to be an ATPase that pumped hydrophobic drugs, was hypothesized by Miguel Valverde and Christopher Higgins to also serve as a swelling-activated chloride channel [2] . The stimulus to link VSOAC and MDR rose from using homologous structure to predict homologous function (form=function). Investigators began with an examination of domain similarities between MDR and the recently cloned cystic fibrosis protein (CFTR). When the evidence that CFTR was an intrinsic Cl -channel became unequivocal [37] [38] [39] , it was suggested that MDR might also be a Cl -channel, and have dual roles as ion channel and efflux pump [2] .
Valverde and Higgins tested their hypothesis by comparing Cl -currents in cells that did or did not express MDR. They found that swelling-activated Cl -currents occurred only in cells when MDR protein was expressed, therefore concluding that MDR was a swelling-activated Cl -channel (VSOAC) [2] . This was followed by detailed studies from the same investigators that confirmed and extended the original work [40] [41] [42] [43] [44] as well as developed elegant models to explain how this bifunctionality worked [45] . They had shown that MDR functioned alternately as either a Cl -channel or an efflux pump, with the two functional states being mutually exclusive [40] .
Why was this Finding Controversial?
These reports generated a great deal of interest [46] and to this day many scientists believe that the story ended there, however, other laboratories still needed to confirm their work. Experienced electrophysiologists also found the findings quite surprising, since they experienced large swelling currents throughout their studies [47] even though MDR expression was not ubiquitous. This "disconnect" was immediately recognized by scientists who studied VSOAC swelling currents and a number of groups went to work to test MDR for VSOAC activity [48] [49] [50] [51] [52] [53] [54] [55] [56] .
Is MDR Expression Related to VSOAC Activity?
One of the first publications to report a close examination of MDR for swelling channel activity was that of Rasola et al. (1994) [57] . Throughout 1992, they carefully tested four epithelial cell lines (LoVo/H LoVo/Dx; 9HTEo-9HTEo-/Dx) both for the expression of MDR-1 gene and for the presence of volume-sensitive Cl -currents. They found greatly elevated expression of MDR protein in Dx, (doxorubicin-selected) lines but Cl -current was unchanged.
Like Rasola, our laboratory (Krouse, Luckie and Wine at Stanford) felt that the question of whether MDR was a Cl -channel, was too important to ignore. Given that the techniques of patch clamp electrophysiology are extremely good at determining whether a protein is a channel or not, it seemed like a relatively simple question to test. In October of 1993, we presented our findings at the North American Cystic Fibrosis Conference [58] reflecting that we saw no evidence to prove that MDR could be a channel. However, Christopher Higgins, Deborah Gill and Stephen Hyde presented enough new evidence [pers. comm., 1993] to support their hypothesis and we were convinced to go back to the lab and conduct further experiments. After numerous additional trials we felt certain our data was solid and published our work [59] .
Perhaps the most comprehensive study published on this topic was that of Ehring et al. 1994 [60] . This well designed study from Michael Cahalan's laboratory was published in The Journal of General Physiology at the end of 1994, after a dozen reports had debated the issue since Rasola et al. [57] . Ehring studied control and MDR1-transfected NIH-3T3 cells selected in colchicine, as well as control and doxorubicin-selected myeloma cells [60] . Both MDR expression and Cl -currents were characterized through a battery of tests including rhodamine efflux, cell volume measurements and whole cell patch clamp. In the end they reported that "The rates of induction, biophysical properties and magnitude of Cl -conductance were indistinguishable between control and corresponding multidrug-resistant cells" [60] . During this period, numerous studies using many cell types and methods for manipulating MDR protein expression and for assessing channel activity [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] also reported the lack of a correlation between MDR expression and the presence of VSOAC currents. All of them concluded that the MDR protein was not the VSOAC channel. It is now clear that MDR is not bifunctional (at least in this way).
Epilogue
Today Higgins and Valverde agree that MDR is not VSOAC or likely any channel yet they continue their investigations into the possibility that MDR may yet be shown to regulate VSOAC and thus strive to find the molecular identity of the ubiquitous swelling activated Cl -channel [44, 71] . One line of evidence that supports the idea that MDR regulates VSOAC, is that in recent years the structurally homologous ABC proteins CFTR and SUR have been shown to regulate other channels [71] . It seems apparent that after the molecular identity of VSOAC is found, the mechanism by which MDR could alter the activity of VSOAC may be clarified.
ABC TRANSPORTERS 2002: "IS CFTR BIFUNC-TIONAL?"
Cystic fibrosis (CF) is caused by mutations in CFTR, an apical membrane anion channel involved in epithelial fluid secretion and salt absorption [29] [30] [31] [32] . The most important aspects of CF's pathophysiology arise from alterations in extracellular fluids, such as, premature activation of pancreatic enzymes, increased thickness of mucus and consequent ductal blockage and irritation [28] . Manifestations of CF in some organs have been difficult to be attributed solely to a defect in Cl -conductance [28] and various investigators have documented changes in other properties as well [3] . For years investigators have been aware that HCO 3 -secretion in the CF pancreas was impaired [72] . Peter Durie and others in the 1980's [73] [74] [75] demonstrated that the CF pancreas has both chloride and bicarbonate secretion defects. Yet recently the question has been extended to the aspects of bicarbonate conductance associated with other organs impaired in the disease, in particular the lung [76] [77] [78] [79] . Secretion of HCO 3 -(as well as H+) may be critical to pH and various cell studies have yielded evidence that pH homeostasis is dependent upon CFTR function [80] [81] [82] [83] [84] . Studies have focused on pH as well as the capacity of CFTR to conduct bicarbonate ions [77, [85] [86] [87] [88] or alter bicarbonate transport through other pathways [85, 87, [88] [89] [90] [91] [92] , and in late 2001, Paul Quinton convened an "International Symposium on HCO 3 -and Cystic Fibrosis" on the topic [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [93] [94] .
As a result, the topic, "CFTR and bicarbonate," has become a hot subfield for those who study ABC Trans-porters [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [93] [94] and the question of bifunctionality has also raised its head for the CFTR in 2002, as it did for MDR in 1992.
Is CFTR Both a Cl
-Channel and HCO 3 -/Cl -Exchanger?
In a series of recent papers the research group of Shmuel Muallem has tightly linked apical exchange of HCO 3 -and Cl -to CFTR [16, 78, 84, 90] and present the novel idea (as well as convincing data) that much of cystic fibrosis may really be a result of defective bicarbonate transport [76] . In a recent report in the journal Nature, [76] examined a variety of CFTR mutants and recorded HCO 3 -movement with pH sensitive dye (BCECF). They found that several mutants known to cause the disease exhibited normal Cl -conductance but impaired HCO 3 -transport. These results suggested that HCO 3 -flux might be more relevant to CF status than Cl -movement. If that wasn't revolutionary enough, Muallem's group, in their latest paper [95] have suggested that CFTR is both a Cl -/ HCO 3 -exchanger and a chloride channel. While they found that HCO 3 -efflux from cells is dependent on activated CFTR, they found no evidence that HCO 3 -anion moves through the pore of the CFTR channel [76, 95] .
Why is this Finding Controversial?
These reports have generated a great deal of interest [4, 96] , however, other laboratories still need to confirm their work. Experienced electrophysiologists also find these findings quite surprising, since some of them have recorded bicarbonate conductance through what they assumed to be the pore of the CFTR channel [39, [80] [81] [97] [98] [99] [100] . Even earlier data from the Muallem laboratory may even oppose their own hypothesis but putting that aside let's just examine this general model. In evaluating whether CFTR is both a Cl -channel and anion exchanger, many questions immediately come to mind, but let us review the basics first: (i) Does HCO 3 -secretion require CFTR?, (ii) Does CFTR activity effect extracellular pH? (iii) Can HCO 3 -move through the CFTR pore? Does Bicarbonate Secretion Require CFTR? Ballard et al. (1999) [85] found that in pig submucosal glands both Cl -and HCO 3 -secretion are dependent on CFTR. In these whole trachea preparations, because CFTR can conduct both Cl -and HCO 3 -, there is no need to invoke the presence of a Cl -/ HCO 3 -exchanger. However, Clarke and Harline (1998) [87] found in mouse intestine a CFTRdependent Cl -/ HCO 3 -exchange. This could be due to CFTR upregulating the expression of an exchanger, regulating a separate exchanger, or being an exchanger itself. In CFT-1 lines Wheat et al. (2000) [101] found AE activity and expression of DRA (a protein implicated in the apical anion exchange) to be upregulated in CFTR expressing cells. They suggested that CFTR Cl -channel activity and direct interaction with DRA both serve to direct HCO 3 -movement.
These reports link bicarbonate exchange to CFTR activity and thus given that at physiological conditions HCO 3 -ions would efflux from epithelia [99] one might expect CFTR to effect extracellular pH (pHo).
Does CFTR Activity Effect Extracellular pH?
Abnormalities in pH have been seen in the CF field before but never assumed to be critical beyond the pancreas [81-82, 89, 102-103] . In recent experiments in our own laboratory (Luckie & Wilterding at Michigan State) [104] we found that C127 cells expressing CFTR alkalinized the extracellular solution after forskolin stimulation whereas non-CFTR expressing cells did not. Using the same cell line (C127) Zegarra-Moran et al. (2001) [105] built upon previous work [106] , and also found that CFTR regulates the HCO 3 -pathway. Recently, Jayaraman et al. (2002) has also examined the question of pHo and found otherwise [107] . They used an in situ fluorescence method to measure the ionic composition, pH and viscosity of freshly secreted fluid from human submucosal airway glands and found; "(Compared to controls) Neither [Na+] nor pH differed in gland fluid from CF airways" [107] . Thus, more studies need to be carried out to clarify if epithelial pHo does change (and in which organs) in cystic fibrosis.
Can HCO 3
-Move Through the CFTR Pore?
CFTR was shown to be a chloride channel in bilayer experiments by Christine Bear [39] and since then various investigators have examined HCO 3 -conductance through CFTR [97] [98] [99] [100] . Linsdell et al. 1997 [97] performed an elegant single channel study with CHO cells and determined that bicarbonate's permeability through CFTR is 14-25% of chloride's. Later, Machen's group [99] measured the permeability of CFTR to bicarbonate using single channel techniques in transfected NIH 3T3 or C127 cells [80] , bovine tracheal cells [79] and Calu-3 cells [100] . They reported evidence that bicarbonate does go through CFTR and that the permeability of bicarbonate is ~25% of that of chloride. In Ussing chamber experiments with Calu-3 cells (short circuit) Krouse et al. [108] presented evidence that 50%-90% of the bicarbonate current is going through open CFTR. Lazrak A et al. (2002) found CFTR dependent HCO 3 -currents in rat fetal distal lung epithelial (FDLE) cells [5] and Sun et al. (2002) found it in bovine corneal endothelial cells [6] .
While several research groups have reported evidence that HCO 3 -can travel through the CFTR pore, in addition to Choi et al. inability to detect it, Devor et al. (1999) [88] found that bicarbonate secretion was dependent upon CFTR but might not go through the CFTR pore; moreover Reddy and Quinton (2002) [14] have found conditions where CFTR exhibits Cl -conductance without HCO 3 -in the sweat gland [14] . Perhaps this question of whether CFTR is a HCO 3 -/Cl -exchanger -, is too important to ignore.
Epilogue or Prologue?
The powerful effects of these findings have been mitigated somewhat by commentaries in the recent reviews [4, 96] and in particular Jeffrey Wine provides data that at least one of the mutations (R1070Q), reported by Choi et al. as "pancreatic sufficient," is not so, thus breaking the perfect correlation with bicarbonate movement and pancreatic sufficiency [96] . More work is needed to determine the significance of the relationship between cystic fibrosis and bicarbonate movement. Even if CFTR is not truly a bifunctional protein, given that the CFTR has a "velcro-like" PDZ domain [16] that can bind to other transporters with PDZ regions, it's interaction with NHE and other AEs along the apical membrane might create not only a bifunctional but a multifunctional complex that could implicate "HCO 3 - conductance defects" as a potentially universal problem in the multi-organ pathology which is cystic fibrosis.
CONCLUSION: RETURN TO CURRENT GENOMICS
It is interesting to see how the functional aspects of these ABC gene products have evolved in the literature. When first cloned they were assumed to be analogous transporters, just like other ABC proteins. When CFTR was found to be different (a Cl -channel), MDR was immediately tested for Cl -conductance. Although CFTR and MDR have since been shown to be different, in the light of the phylogenetic similarities in this gene family, what lessons concerning functional genomics can be learned from this?
The phylogeny of the ABC transporter family has previously been characterized [20, 23] . The ubiquity of ABC cassette motif and walker domains in the human genome suggests the widespread utility of this sequence in many proteins [20, 21] . A potential hypothesis is that the genetic homology shared by ABC transporters was a result of gene evolution by exon-shuffling [109] [110] . Briefly, in this model, new novel proteins are assembled in part from preexisting subunits that are mixed and matched with others to form genes that assume new and novel functions [111] [112] [113] . If this is so, it might be attractive to assume that since a new gene in question shares one or more subunits found in other related genes [114, 115] , its protein might share analogous properties with those related proteins.
Indeed, as we have seen, the pairing of MDR and CFTR with other ABC transporters lead to the early, and partly inaccurate assumption as to the functional aspects of MDR and CFTR [2, [40] [41] [42] [43] [44] [45] . However, as we have seen, the situation is far more complex, but these results should not be viewed as surprising or discouraging. Studies of exon 9 shuffling in CFTR support Walker A likely went through a series of duplications, amplification and dispersion throughout the human genome in evolution [24] . If a mechanism such as exon-shuffling did in fact give rise to new proteins, it would bring a well characterized domain (like the Walker A domain) into a new association with other disparate flanking sequences [116] . The molecular interactions (folding, bonding interactions, hydrophobicity, etc.) in this new environment may change the functional nature of the domain [117] . For example, an examination phylogenetic tree of ABC transporters reveals that CFTR (ABCC7), a Cl -channel has greatest sequence homology to SUR (ABCC8), a sulfonylurea receptor. Therefore, while the known function of one gene can be useful in generating hypotheses as to the functional nature of another gene to which it share homologous domains, this should be done so with caution.
In the realm of functional genomics then, a credible phylogeny of gene families may only have limited application in developing a meaningful taxonomy to aid in the study of the origin of a gene. For example, Martinoia et al. (2002) [22] , found that while being structurally-related, ABC transporters in plants in fact served diverse physiological functions. As a result, domain homologies may provide researchers with reasonable starting points, but ultimately they may imply little, if anything definitive concerning the actual function. Interestingly the examination of the large-scale organization of cell components into higher order complexes called "modules" appears to be an interesting new area of study [118] . Even in this, at the more macroscopic level, surprisingly, one particular protein can serve distinctly different functions in separate parts of the same cell [119] . The whole depends on process neighboring proteins and ultimately it's "context."
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